previous compound ID: 1883 next compound
InChIKey: QWCJHSGMANYXCW-UHFFFAOYSA-N
SMILES: C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "R Robert" "JW Hanrahan" "J Liao" "GW Carlile" "B Kus" "SD Macknight" "E Matthes" "DY Thomas" "D Rotin"

chemical graph of compound 1883





CID is 5335
synonyms found at PubChem are:
sulfaphenazole, Sulphaphenazole, Sulfabid, 526-08-9, Sulfafenazol, Sulfaphenazol, Sulfaphenazon, Sulphenazole, Sulfaphenylpyrazole, Sulfaphenylpipazol, Sulfafenazolo, Sulfaphenazolum, Plisulfan, Raziosulfa, Depocid, Depotsulfonamide, 4-Amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide, Eftolon, Firmazolo, Paidazolo, Inamil, Isarol, Merian, Orisul, Microtan pirazolo, 1-Phenyl-5-sulfanilamidopyrazole, 5-Sulfanilamido-1-phenylpyrazole, Sulfaphenylpyrazol, Phenylsulfapyrazole, Sulfafenazolo [Italian], N'-(1-Phenylpyrazol-5-yl)sulfanilamide, Solfafenazolo, Sulfafenazol [INN-Spanish], Sulfaphenazol [INN-French], Solfafenazolo [DCIT], Sulfaphenazolum [INN-Latin], 3-(p-Aminobenzenesulfonamido)-2-phenylpyrazole, Benzenesulfonamide, 4-amino-N-(1-phenyl-1H-pyrazol-5-yl)-, UNII-0J8L4V3F81, Orisulf, N1-(1-Phenylpyrazol-5-yl)sulfanilamide, Isarol V, Sulfaphenazole [INN:JAN], Prestwick_454, C15H14N4O2S, N(sup 1)-(1-Phenylpyrazol-5-yl)sulfanilamide, EINECS 208-384-3, Lopac-S-0758, Sulfaphenazole (JAN/INN), 4-amino-N-(2-phenylpyrazol-3-yl)benzenesulfonamide, BRN 0308518, CHEMBL1109, CHEBI:77780, QWCJHSGMANYXCW-UHFFFAOYSA-N, 0J8L4V3F81, NCGC00015925-02, CAS-526-08-9, N(1)-(1-Phenylpyrazol-5-yl)sulfanilamide, Sulfanilamide, N1-(1-phenylpyrazol-5-yl)-, DSSTox_CID_24131, DSSTox_RID_80106, DSSTox_GSID_44131, Sulfanilamide, N(sup 1)-(1-phenylpyrazol-5-yl)-, 4-Amino-N-(1-phenyl-1H-pyrazol-5-yl)-benzenesulfonamide, 4-Amino-N-(2-phenyl-2H-pyrazol-3-yl)-benzenesulfonamide, Sulfanilamide, N(sup 1)-(1-phenylpyrazol-5-yl)- (8CI), SMR000326684, SR-01000075649, [(4-aminophenyl)sulfonyl](1-phenylpyrazol-5-yl)amine, Sulfonylpyrazol, Sulfaphenazole [INN:BAN:JAN], Sulfabid (TN), Sulfaphenazole/Sulfabid, Spectrum_001406, Prestwick0_000021, Prestwick1_000021, Prestwick2_000021, Prestwick3_000021, Spectrum2_001943, Spectrum3_001741, Spectrum4_000443, Spectrum5_001185, Sulfaphenazole, >=98%, D0A4YE, AC1L1K4K, UC166_SIGMA, Lopac0_001095, BSPBio_000081, BSPBio_003442, KBioGR_000826, KBioSS_001886, 5-25-09-00415 (Beilstein Handbook Reference), MLS000859612, MLS001056713, DivK1c_000303, S0758_SIGMA, SCHEMBL122040, SPECTRUM1501143, SPBio_002002, SPBio_002005, BPBio1_000091, DTXSID2044131, CTK8G3260, HMS500P05, KBio1_000303, KBio2_001886, KBio2_004454, KBio2_007022, KBio3_002662, ZINC57490, MolPort-002-070-488, NINDS_000303, HMS1568E03, HMS1921J13, HMS2095E03, HMS2235J21, HMS3263K12, HMS3373E16, HMS3712E03, Pharmakon1600-01501143, Sulfaphenazole, >=98% (HPLC), ALBB-025160, BCP27626, HY-B1218, ZX-AN023674, Tox21_110262, Tox21_501095, ABP000631, BDBM50090677, CCG-39431, MFCD00057226, NSC757859, Pyrazole, 1-phenyl-5-sulfanilamido-, SBB018383, STK663863, AKOS003348743, Tox21_110262_1, API0025190, CS-4843, DB06729, LP01095, MCULE-5658431414, NSC-757859, IDI1_000303, NCGC00015925-01, NCGC00015925-03, NCGC00015925-04, NCGC00015925-05, NCGC00015925-06, NCGC00015925-07, NCGC00015925-08, NCGC00015925-09, NCGC00015925-10, NCGC00015925-12, NCGC00015925-13, NCGC00094368-01, NCGC00094368-02, NCGC00094368-03, NCGC00094368-04, NCGC00094368-05, NCGC00261780-01, AN-16915, LS-31277, SC-66871, ST078027, SBI-0051065.P003, AB2000163, AB00052218, EU-0101095, FT-0761575, R1865, Z3406, BIM-0051065.0001, D01954, S 0758, AB00052218_10, C-44305, 3-(p-Aminobenzenesulfonamido)-2-pheny-2H-lpyrazole, SR-01000075649-2, SR-01000075649-7, SR-01000075649-8, SR-01000075649-9, BRD-K10671814-001-05-6, BRD-K10671814-001-09-8, 4-amino-N-(1-phenyl-1H-pyrazol-5-yl)-1-benzenesulfonamide, 4-amino-N-(1-phenyl-1H-pyrazol-5-yl)benzene-1-sulfonamide